Breast Parallel Session 1

Friday, March 22, 2024

10:30am – 12:00pm ET

Location:Georgia Ballroom

Moderator(s)

Meeghan Lautner, MD, MSc, FACS (she/her/hers)

Associate Professor
University of Wisconsin Department of Surgery

Disclosure(s): No financial relationships to disclose
Kathie Ann Joseph, MD, MPH (she/her/hers)

Professor of Surgery
NYU
New York, New York, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Meeghan A. Lautner, MD, MSc, FACS: No financial relationships to disclose

Kathie Ann Joseph, MD, MPH: No financial relationships to disclose

Presentations:

10:32am – 10:42am ET

11: A Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein 2 Inhibits TNBC Lung Metastases
Abstract Presenter: Lillian Hsu, MD (she/her/hers) – MUSC
Submitter: Lillian Hsu, MD (she/her/hers) – MUSC
Author: Lillian Hsu, MD (she/her/hers) – MUSC
Author: Patrick Nasarre, PhD – MUSC
Author: Julie B. Siegel, MD (she/her/hers) – MUSC
Author: Eleanor Hilliard, BS – MUSC
Author: Rupak Mukherjee, PhD – MUSC
Author: Nancy Klauber DeMore, MD – MUSC
10:42am – 10:52am ET

9: The Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Abstract Presenter: Jennifer F. Carroll, MD, FACS – Mayo Clinic
Submitter: Jennifer F. Carroll, MD, FACS – Mayo Clinic
Author: Tanya L. Hoskin, MS – Mayo Clinic
Author: Roberto A. Leon Ferre, MD – Mayo Clinic
Author: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
10:52am – 11:02am ET

8: A high pre-existing TCR repertoire diversity may predict response to preoperative radiotherapy and pembrolizumab in early-stage breast cancer – NCT04454528 preliminary results
Author: Fengjuan Zhang, PhD – University of Pennsylvania
Author: Joseph Fraietta, PhD – Universiy of Pennsylvania
Author: Amy Clark, MD – University of Pennsylvania
Author: Neil taunk, MD – University of Pennsylvania
Author: Nucleus H Xu, PhD – University of Pennsylvania
Author: Anupma Nayak, MD – University of Pennsylvania
Author: Zahra Ahmad, BS – University of Pennsylvania
Author: Diego Gonzalves, BA – University of Pennsylvania
Author: Alexander C Huang, MD – University of Pennsylvania
Author: Andy Minn, MD PhD – University of Pennsylvania
Abstract Presenter: Julia Tchou, MD PhD – University of Pennsylvania
Submitter: Julia Tchou, MD PhD – University of Pennsylvania
11:02am – 11:12am ET

5: Change in Biomarker Profile after neoadjuvant chemotherapy is especially common in patients with HER2+ breast cancer subtype
Abstract Presenter: Soumy Gottipati, BS (she/her/hers) – UCSF
Author: Soumy Gottipati, BS (she/her/hers) – UCSF
Author: molly Baxter, BA – UCSF
Author: Yunn-yi Chen, MD PhD – UCSF
Author: Sara J Venters, PhD – UCSF
Author: Macy Goldbach, BS – University of Pennsylvania
Author: Diego Gonzalves, BA – University of Pennsylvania
Author: Anupma Nayak, MD – University of Pennsylvania
Author: Rita A. Mukhtar, MD – University of California, San Francisco
Author: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
Author: Julia Tchou, MD PhD – University of Pennsylvania
11:12am – 11:22am ET

10: Potential Overtreatment of DCIS in Patients with Limited Life Expectancy
Abstract Presenter: Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital
Submitter: Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital
Author: Eliza Hersh Lorentzen, MD – Brigham and Women's Hospital
Author: Yu-Jen Chen, MPH – Center for Surgery and Public Health, Brigham and Women's Hospital
Author: Tari A. King, MD (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute
Author: Elizabeth A. Mittendorf, MD, PhD, MHCM (she/her/hers) – Brigham and Women's Hospital, Dana Farber Cancer Institute
Author: Christina A. Minami, MD, MS (she/her/hers) – Brigham and Women's Hospital, Dana-Farber Cancer Institute
11:22am – 11:32am ET

6: Impact of clipped node as a sentinel lymph node on axillary staging following neoadjuvant chemotherapy in clinically node-positive breast cancer
Abstract Presenter: Alexandra Moore, MD – MD Anderson Cancer Center
Submitter: Alexandra Moore, MD – MD Anderson Cancer Center
Author: Alexandra Moore, MD – MD Anderson Cancer Center
Author: Abigail S. Caudle, MD, MS, FACS – MD Anderson Cancer Center
Author: Susie X. Sun, MD – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Author: Henry M. Kuerer, MD, PhD – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Kelly K. Hunt, MD (she/her/hers) – Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Savitri Krishnamurthy, MD – MD Anderson Cancer Center
Author: Wei Yang, MBBS, FRCR – MD Anderson Cancer Center
Author: Benjamin D. Smith, MD – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA
Author: Vicente Valero, MD, FACP – MD Anderson Cancer Center
Author: Mediget Teshome, MD (she/her/hers) – UCLA
11:32am – 11:42am ET

4: International Validation of a Staging Model for de novo Metastatic Breast Cancer
Abstract Presenter: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
Submitter: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
Author: Jennifer K. Plichta, MD, MS (she/her/hers) – Duke University School of Medicine
Author: Samantha M. Thomas, MS – Duke Cancer Institute
Author: Sabine Siesling, PhD – Department of Research and Development, Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands; Department of Health Technology andServices Research, University of Twente, Technical Medical Centre, Enschede, TheNetherlands
Author: Linda De Munck, MSc – Department of Research and Development; Netherlands Comprehensive CancerOrganisation (IKNL), Utrecht, The Netherlands
Author: Amélie Lusque, MS – Biostatistics & Health Data Science Unit, Institut Claudius Regaud, IUCT-oncopole,Toulouse, France
Author: Thomas Grinda, MD, MSc – Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800Villejuif, France
Author: Lovedeep Gondara, PhD, MS – BCCancer –Data and Analytics
Author: Stephen Chia, MD, FRCP – Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
Author: Paula Cabrera-Galeana, MD, MSc – Breast Medical Oncology Department, Instituto Nacional de Cancerología
Author: Nancy Reynoso-Noverón, MD, MS – Instituto Nacional de Cancerología, CDMX, México
Author: Sara López-Tarruella Cobo, MD, PhD – Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria GregorioMarañón (IiSGM), Universidad Complutense. CIBERONC-ISCIII. GEICAM Spanish BreastCancer Group. Madris, Spain
Author: Isabel Alvarez Lopez, MD – Medical Oncology Unit of Donostia University Hospital (Donostialdea IHO); GEICAM,Madrid, Spain
Author: Stephen B. Edge, MD (he/him/his) – Department of Surgical Oncology and Cancer Prevention and Control, University atBuffalo. Buffalo, NY, USA; Roswell Park Comprehensive Cancer Center. Buffalo, NY, USA
Author: Gabriel Hortobagyi, MD – Department of Breast Medical Oncology, Division of Cancer Medicine, The University ofTexas MD Anderson Cancer Center, Houston, TX, USA
11:42am – 11:52am ET

7: Routine Use of Cavity Shave Margins with Breast Conserving Surgery Lowers Re-Excision Rates in a High Volume, Large Group Practice
Abstract Presenter: Jeffery Chakedis, MD, FACS – The Permanente Medical Group
Submitter: Jeffery Chakedis, MD, FACS – The Permanente Medical Group
Author: Jeffery Chakedis, MD, FACS – The Permanente Medical Group
Author: Annie Tang, MD – University of California San Francisco
Author: Gillian Kuehner, MD – The Permanente Medical Group
Author: Alison Savitz, MD – The Permanente Medical Group
Author: Maris Jones, MD – The Permanente Medical Group
Author: Lakhbir Sandhu, MD – The Permanente Medical Group
Author: Mindy Young-Reeves, MD – The Permanente Medical Group
Author: Maihgan Kavanagh, MD – The Permanente Medical Group
Author: Sharon Chang, MD – The Permanente Medical Group